MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Neurology

Section

Neurology

972 articles

Ask AI
All specialtiesNeurologynewsClinical UpdatesCardiologyOncology

Latest updates

Critical Care

Adjuvant Systemic Hypothermia During Mechanical Thrombectomy: Feasibility and Clinical Insights from the ReCCLAIM II Trial

The ReCCLAIM II trial demonstrates that rapid systemic hypothermia during mechanical thrombectomy for large-vessel occlusion stroke is feasible without delaying reperfusion, showing trends toward reduced infarct volume but raising safety co

Oct 22, 2026
Neurology

Influence of Age, Resilience, Social Support, and Health Literacy on Functional Recovery Following Traumatic Spinal Cord Injury: Insights from a 6-Month Follow-up Study

A 6-month longitudinal study identifies younger age, higher resilience, and better health literacy as key predictors of functional ability improvement in traumatic spinal cord injury patients, highlighting targets for tailored rehabilitatio

Oct 22, 2026
Neurology

Phase-Dependent Effects of Electrical Stimulation on Bell’s Palsy Recovery: Risks of Early Overuse and Benefits in Chronic Sequelae

This study reveals that aggressive electrical stimulation during acute Bell’s palsy recovery may worsen synkinesis and reduce botulinum toxin efficacy, while chronic-phase stimulation improves function, emphasizing a critical cumulati

Oct 22, 2026
Neurology

Predictive Value of Midlife and Late-Life Blood Biomarkers for Alzheimer’s Disease and Long-Term Cognitive Decline

This study reveals that midlife plasma p-tau181 predicts faster memory decline over 11 years, highlighting a long prodromal phase of Alzheimer’s disease. Late-life biomarkers p-tau181, NfL, and GFAP correlate with accelerated cognitive decl

Oct 22, 2026
Infectious Diseases

Exploring the Link Between Common Infections and Alzheimer’s Disease Neuropathology: Insights From a UK Prospective Cohort Study

A large-scale UK cohort study found no strong associations between antibodies against multiple common infections and key Alzheimer’s disease neuropathologies, though possible interactions with APOE ε4 genotype and education warrant further

Oct 21, 2026
Neurology

Impact of APOE ɛ4 and ɛ2 Alleles on Cognitive Trajectories in Nonagenarians and Beyond: Insights from the LifeAfter90 Study

This study illuminates how APOE ɛ4 accelerates executive function decline while ɛ2 may protect verbal episodic memory in individuals aged 90+, highlighting genetic influences on cognition in exceptional longevity.

Oct 20, 2026
MMedXY
News
Clinical Updates

Global Incidence of All-Cause Dementia: A Comprehensive Meta-Analysis and Contemporary Insights

This review synthesizes global dementia incidence from the COSMIC consortium, highlighting variations by age, sex, and economic regions, with implications for prevention and resource planning, informed by recent meta-analyses on risk factor

Oct 20, 2026
Neurology

Epilepsy as a Significant Risk Factor for Young-Onset Dementia: Insights from Nationwide Studies in France and Sweden

Nationwide analyses show that epilepsy markedly increases the risk of young-onset dementia (YOD) before age 65, with persistent associations even years after epilepsy diagnosis, underscoring the need for YOD risk assessment in epilepsy care

Oct 19, 2026
Neurology

Assessing Early Pregnancy Exposure to Anti-CGRP Monoclonal Antibodies and Propranolol: Implications for Spontaneous Abortion Risk

This study evaluates the association between early pregnancy use of anti-CGRP monoclonal antibodies or propranolol and spontaneous abortion risk, finding increased risk with anti-CGRP mAbs but not with propranolol.

Oct 19, 2026
Clinical Updates

Long-term Effects of Spinal Cord Stimulation Combined with Physiotherapist-led Exercise and Prescribed Physical Activity in Chronic Neuropathic Pain: A Clinical Review

This review synthesizes evidence on spinal cord stimulation combined with physiotherapist-led exercise and physical activity prescriptions, highlighting sustained pain relief and quality-of-life improvements without significant increases in

Oct 18, 2026
Clinical Updates

Safety and Efficacy of Delpacibart Zotadirsen in Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping: Insights from the EXPLORE44 Phase 1/2 Trial

Delpacibart zotadirsen demonstrates an acceptable safety profile and significant increases in exon 44 skipping and dystrophin expression in DMD patients amenable to exon 44 skipping, supporting further phase 3 evaluation.

Oct 18, 2026
Cardiology

Evaluating Bleeding Risks of Asundexian in Noncardioembolic Ischemic Stroke or High-Risk TIA: Insights from the OCEANIC-STROKE Trial

The OCEANIC-STROKE randomized trial demonstrates that adding asundexian to antiplatelet therapy reduces ischemic stroke without a significant rise in major bleeding, though it increases lower gastrointestinal bleeding in patients with nonca

Oct 18, 2026
Neurology

Elevated Risk of Training-Related Concussions in Elite English Premiership Rugby: Eight-Season Prospective Cohort Analysis

An eight-season study reveals increased concussion incidence during preseason and full-contact training in men’s English Premiership Rugby, emphasizing the need for strategic training modifications to reduce injury risk.

Oct 18, 2026
Clinical Updates

Plasma Phosphorylated Tau 217 Percentage by Race and Ethnicity in Preclinical Alzheimer Disease: Implications for Screening and Biomarker Utility

This review synthesizes evidence on racial and ethnic differences in plasma phosphorylated tau 217 (%p-tau217) in preclinical Alzheimer disease, highlighting implications for diagnostic screening and biomarker validity across diverse popula

Oct 17, 2026
Neurology

Impact of Time-Varying Social Integration on Mortality Following Traumatic Spinal Cord Injury: Insights from the SCIMS Longitudinal Study

This study reveals that lower and declining social integration significantly increase long-term mortality risk after traumatic spinal cord injury, highlighting critical social determinants alongside clinical factors.

Oct 17, 2026
Neurology

Adjuvant Radiotherapy Reduces Recurrence After Complete Resection of WHO Grade 2 Atypical Meningioma: Insights from the ROAM/EORTC-1308 Phase 3 Trial

The ROAM/EORTC-1308 trial demonstrates that adjuvant radiotherapy after complete surgical resection of atypical meningioma significantly improves 5-year disease-free survival, reducing recurrence risk with manageable adverse effects.

Oct 16, 2026
Neurology

Hematoma Location as a Key Modifier of Intensive Blood Pressure Lowering Outcomes in Acute Intracerebral Hemorrhage

This pooled analysis of INTERACT and ATACH-II trials reveals that intensive blood pressure lowering significantly improves outcomes only in patients with deep intracerebral hemorrhage, highlighting hematoma location as crucial for personali

Oct 16, 2026
Clinical Updates

Effectiveness of Office-Based Vergence/Accommodative Therapy with Movement for Accommodative Dysfunction in Concussion-Related Convergence Insufficiency: Insights from the CONCUSS Randomised Clinical Trial

Office-based vergence/accommodative therapy with movement (OBVAM) significantly improves accommodative amplitude and facility in adolescents and young adults with concussion-related convergence insufficiency, accelerating recovery and funct

Oct 16, 2026
Neurology

Comparative Effectiveness of High-Intensity Laser Therapy Versus Shock Wave Therapy in Post-Burn Cubital Tunnel Syndrome: A Randomized Controlled Trial

This RCT demonstrates that high-intensity laser therapy combined with ulnar nerve gliding exercises yields superior electrophysiological and functional recovery in post-burn cubital tunnel syndrome compared to shock wave therapy or exercise

Oct 16, 2026Sign in to read
Neurology

Streamlining Social Cognition Assessment Post-Traumatic Brain Injury: Validity and Reliability of the Norwegian Short-Awareness of Social Inference Test

This article discusses the development and validation of a concise Norwegian tool to assess social cognition deficits in traumatic brain injury patients, maintaining reliability and clinical feasibility compared to the full version.

Oct 15, 2026
Previous
5 / 25
1…34567…25
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.